EHC — Encompass Health

Median target
$150
calls from the last 12 months
Implied return
+11.3%
median target vs. price
Coverage
12 analysts · 12 calls
updated in the last 12 months
Consensus
12/0/0+12 net
Buy / Hold / Sell

Which analysts are behind EHC's consensus?

See every current rating, price target and the analysts' track records for Encompass Health — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 12 analysts with calls on EHC updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

EHC elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2025-10-31CongressLisa McClainMI-MI09Salesince trade +18.6%, vs market -7.4%$1K–$15K
2025-01-29ExecutiveTrump, Donald JPresidentPurchaseENCOMPASS HEALTH CORP$15,001 - $500,001
2021-02-16CongressPeter MeijerMI-MI03Salesince trade +121.8%, vs market -15.3%$1K–$15K
2019-07-31CongressSusie LeeNV-NV03Salesince trade +187.2%, vs market -7.1%$1K–$15K
2019-03-15CongressSusie LeeNV-NV03Purchasesince trade +209.8%, vs market +12.1%$1K–$15K

More: congressional trades on EHC · insider activity · executive branch · trending